Anavex Life Sciences Corp.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-13.5M | $-14.7M | $-12.1M | $-10.0M | $-3.7M | $-8.3M | $-7.3M | $-8.8M |
| Depreciation & Amortization | — | $1.3K | $995 | $768 | $576 | $1.9K | $1.7K | $910 |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $4.1M | $5.1M | $1.6M | $637.9K | $1.0M | $302.2K | $1.3M | $770.1K |
| Net Cash from Operating Activities | $-9.0M | $-9.2M | $-4.2M | $-2.7M | $-777.6K | $-1.7M | $-3.8M | $-4.6M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | $3.0K | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | $-3.0K | $0 | $0 | $0 | $-3.3K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $27.3M | $3.1M | $12.3M | $9.6M | $1.1M | $1.6M | $3.7M | $4.5M |
| Net Change in Cash | — | — | — | $6.9M | $333.7K | $-123.3K | $-130.0K | $-86.3K |
| Free Cash Flow | — | — | — | $-2.7M | — | — | — | — |